Horizons Glbl Vaccs Infect Diseases ETF opened trading today at $0.00 and closed at $15.91. Intraday prices ranged from a low of $0.00 to a high of $0.00.

The price dipped -11.61% from the previous day's close of $18.00.

During the day across North America, the TSX Composite closed -1.51% at 18717.12, the S&P 500 closed 0.95% at 3795.73, the Dow Jones Industrial Average closed 0.64% at 30677.36 and the Nasdaq Composite closed 1.62% at 11232.19.

Horizons Glbl Vaccs Infect Diseases ETF traded under HVAX.TO on the TSX stock exchange.

Trading volume was 0 on 1 total trades. On average, Horizons Glbl Vaccs Infect Diseases ETF has traded 2,122 shares over the last 5-days and 820 year-to-date.

Trading across the entire TSX saw 4,452 price advancers against 1,121 declines and 153 unchanged.

During the prior 52 weeks, HVAX.TO has traded as high as $26.20 (November 29,2021) and low as $0.00 (June 23,2022). Moreover, in the last 52 weeks, Horizons Glbl Vaccs Infect Diseases ETF's shares have shrunken -38.31%, while this year, they have shrunken -35.64%.

Following today's trading, Horizons Glbl Vaccs Infect Diseases ETF has a market capitalization of $2.04 million on a float of 128 shares outstanding. Its annual EPS is $None.

Horizons Glbl Vaccs Infect Diseases ETF is a None company headquartered in, US.

Horizons Glbl Vaccs Infect Diseases ETF is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation that help readers identify investment opportunities across Canadian and US markets. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.